Maze Therapeutics (MAZE) Non-cash Items (2024 - 2026)

Maze Therapeutics has disclosed Non-cash Items across 3 years of filings, most recently posting $58.0 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $58.0 million, up 4361.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.0 million (up 4361.54% YoY), and the FY2025 annual result was $2.7 million, down 90.93% from the prior year.
• Non-cash Items came in at $58.0 million for Q1 2026 at Maze Therapeutics, up from $2.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $58.0 million in Q1 2026 to a low of $1.3 million in Q1 2025.
• The 3-year median for Non-cash Items is $8.3 million (2025), against an average of $17.9 million.
• Across the five-year window, Non-cash Items tumbled 90.93% in 2025 and surged 4361.54% in 2026, its largest moves.
• Maze Therapeutics' Non-cash Items stood at $30.0 million in 2024, then sank by 90.93% to $2.7 million in 2025, then jumped by 2031.29% to $58.0 million in 2026.
• The last three Non-cash Items figures came in at $58.0 million (Q1 2026), $2.7 million (Q4 2025), and $13.9 million (Q3 2025), per Business Quant data.